Bill
Bill > H3574
MA H3574
MA H3574Concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA)
summary
Introduced
03/30/2023
03/30/2023
In Committee
04/13/2023
04/13/2023
Crossed Over
Passed
Dead
12/31/2024
12/31/2024
Introduced Session
193rd General Court
Bill Summary
Relative to the use of a certain prescription medication used in psychotherapy and the treatment of post-traumatic stress disorder. Elder Affairs.
AI Summary
This bill aims to regulate the use of a prescription medicine containing 3,4-methylenedioxymethamphetamine (MDMA), which is used in psychotherapy and the treatment of post-traumatic stress disorder. The key provisions are: 1) Capping the cost of an MDMA treatment service unit, which includes prescribed and controlled administration of MDMA and related therapy, at $5,000; and 2) Removing MDMA from the list of Class B controlled substances in Massachusetts, which would allow for its use as a prescription drug once approved by the U.S. Food and Drug Administration. The bill will take effect upon FDA approval of MDMA as a prescription drug.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Accompanied a study order, see H4739 (on 07/01/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/193/H3574 |
| BillText | https://malegislature.gov/Bills/193/H3574.pdf |
Loading...